鈥� For over 20 years, Dr. Evelina Cohn (Budu) has conducted influential research into Life Sciences at universities and small pharmaceutical companies in Romania, Israel, USA and Canada, including six years as Chief Executive of her own therapeutic skincare company: TelBari Inc.
鈥� Specializing in Lectinology and Pharmacology, Evelina is passionate about discovering the underlying causes and processes of neurodegenerational disorders, confirmed by her recent breakthrough discovery of new biomarkers in the serum of people with Multiple Sclerosis.
Achievements
鈥� Multidisciplinary knowledge in Cell Biology, Biochemistry, Microbiology and Molecular Biology.
鈥� Deep knowledge of procedures
We鈥檝e updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.
